OQROGet OQRO Pro
Politician trade (Senate)

Eli Lilly (LLY)Sen. Angus S King disclosed a sale $1K–$15K

Sen. Angus S King disclosed a sale of Eli Lilly in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
39 days
Disclosure lag
Traded
Feb 13, 2026
Disclosed
Mar 24, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 18, 2025CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  2. Dec 10, 2025CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  3. Dec 18, 2025CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  4. Dec 19, 2025FDAFDA drug approval: Mounjaro
  5. Dec 23, 2025Insider10% owner sold ~$260K of LLY shares in the open market
  6. Dec 24, 2025Insider10% owner sold ~$2.85M of LLY shares in the open market
  7. Dec 29, 2025Insider10% owner sold ~$3.9M of LLY shares in the open market
  8. Dec 29, 2025Congress · 2 peopleMembers of Congress: 2 purchases
  9. Jan 5, 2026Insider10% owner sold ~$1.51M of LLY shares in the open market
  10. Jan 7, 2026Insider · 1 personInsiders: 30 sales (~$322.4M)
  11. Jan 16, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  12. Jan 23, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.8%
  13. Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
  14. Feb 9, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  15. Feb 13, 2026 · this disclosureCongressDisclosed sale of LLY — reported range $1,001 - $15,000

What came next

  1. Feb 26, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  2. Mar 13, 2026CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  3. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  4. Apr 1, 2026FDAFDA drug approval: Foundayo
  5. Apr 2, 2026Congress · 1 personMembers of Congress: 2 purchases
  6. Apr 8, 2026CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  7. Apr 14, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  8. Apr 20, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.7%
  9. Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
  10. May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.5%
  11. May 6, 2026Insider · 1 personInsiders: 2 sales (~$15.8M)
  12. May 15, 2026Federal contract · $52K obligatedDepartment of Veterans Affairs awarded Eli Lilly: $52K obligated to date
  13. Jun 9, 2026FDAFDA drug approval: Ebglyss
  14. Jun 10, 2026Insider · Their largest sale since 2022Officer sold ~$2.88M of LLY shares in the open market
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Eli Lilly

For Eli Lilly, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports, 189 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.

Other recent filings by Sen. Angus S King

The full history of Sen. Angus S King is on the profile page.

How this filing works

Other disclosures at Eli Lilly

Everything OQRO holds on this company is on its LLY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data